United States · FDA National Drug Code directory
COMBIVIR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49702-202_42a6587e-9322-4810-8c72-1dc40f3543d2
- Product NDC
- 49702-202
- Form
- TABLET, FILM COATED
- Composition / generic term
- lamivudine and zidovudine
- Labeler
- ViiV Healthcare Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20101019 / 20270228
Source-listed ingredients
- LAMIVUDINE — 150 mg/1
- ZIDOVUDINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (49702-202-18) · 49702-202-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →